REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,544,183 | +2.5% | 1,211,856 | -1.0% | 0.01% | +10.0% |
| Q2 2023 | $32,734,649 | +34.5% | 1,223,725 | +8.9% | 0.01% | +25.0% |
| Q1 2023 | $24,344,929 | +45.8% | 1,123,958 | +60.4% | 0.01% | +33.3% |
| Q4 2022 | $16,694,000 | -14.7% | 700,923 | -29.4% | 0.01% | -14.3% |
| Q3 2022 | $19,566,000 | +0.3% | 993,063 | -0.8% | 0.01% | 0.0% |
| Q2 2022 | $19,500,000 | -21.2% | 1,001,308 | +3.2% | 0.01% | 0.0% |
| Q1 2022 | $24,754,000 | +2.3% | 970,514 | +1.0% | 0.01% | 0.0% |
| Q4 2021 | $24,196,000 | -8.3% | 961,296 | +0.2% | 0.01% | -12.5% |
| Q3 2021 | $26,393,000 | -11.3% | 959,227 | +2.3% | 0.01% | -11.1% |
| Q2 2021 | $29,740,000 | +54.3% | 937,485 | +123.2% | 0.01% | +50.0% |
| Q1 2021 | $19,269,000 | +79.3% | 420,007 | +54.8% | 0.01% | +50.0% |
| Q4 2020 | $10,744,000 | +513.9% | 271,325 | +440.1% | 0.00% | +300.0% |
| Q3 2020 | $1,750,000 | +24.6% | 50,239 | +13.0% | 0.00% | 0.0% |
| Q2 2020 | $1,404,000 | +0.9% | 44,444 | -30.0% | 0.00% | 0.0% |
| Q1 2020 | $1,392,000 | – | 63,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |